ArticleFrontiers in surgery2026
Short-term efficacy and safety of percutaneous ultrasound-guided pseudomonas aeruginosa-mannose sensitive hemagglutinin injection in postoperative chyle fistula: a cohort study.
Article in Frontiers in surgery, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective: Postoperative chyle fistula is a rare but serious complication following total thyroidectomy with neck dissection, with an incidence of 3%-8% in high-risk patients. Given the variable effectiveness of conservative therapy, this study aimed to evaluate the short-term efficacy and safety of percutaneous ultrasound-guided pseudomonas aeruginosa-mannose-sensitive hemagglutinin (PA-MSHA) injection in postoperative patients. Methods: This retrospective single-center cohort study included 78 patients with papillary thyroid carcinoma who developed postoperative chyle fistula after total thyroidectomy with lateral neck dissection. Patients received either PA-MSHA injection (Group A) or standard conservative therapy including somatostatin and adhesion-agent injection (Group B). Inverse probability of treatment weighting (IPTW) was applied to balance baseline characteristics. Primary endpoints included postoperative length of stay (LOS), number of drug injections, readmission rates, daily drainage volume, and inflammatory responses. Secondary endpoints included side of leakage, unilateral drainage volume and demographic data. Results: All patients recovered without requiring surgical re-intervention. After IPTW adjustment, PA-MSHA treatment was significantly associated with a shorter LOS compared with conservative therapy (7.57 ± 1.49 vs. 8.86 ± 0.38). Daily clinical observations showed a visible reduction in chyle output within 24-48 h after PA-MSHA injection, the POD3/POD2 drainage reduction rate was 37% vs. 44%, not significantly different between groups after weighting, indicating a crude difference confounded by baseline drainage imbalance. Fever and neck pain were more frequent in PA-MSHA group, consistent with its inflammatory mechanism, and no severe complications occurred. Conclusion: Percutaneous ultrasound-guided PA-MSHA injection may serve as a practical adjunct to conservative therapy for postoperative chyle fistula, with a significant reduction in hospitalization duration after IPTW adjustment. Further prospective studies are needed to validate its efficacy and define its optimal clinical application.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.